Meanwhile, a recent in vivo study of SLE based on NZB/NZW.F1 mice revealed that they have significantly lower percentages of CD200-CD200R1-positive cells in their splenocytes with significantly higher plasma anti-dsDNA levels that could be decreased after anti-CD200 treatment [107]. The gene discussed is CD200R1; the disease is systemic lupus erythematosus.